EUVIMEDEUVIMED entdecken
Editorial

Diabetic Kidney Disease — Semaglutide Flows into the Mainstream

William G Herrington iD, Richard Haynes

New England Journal of Medicine · 2024

DOI: 10.1056/nejme2406408 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von William G Herrington und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Renal Studies Group, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of O…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Hypoglycemic Agents, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesHypoglycemic AgentsRenal Insufficiency, ChronicDiabetic CardiomyopathiesHumansDrug ApprovalGlucagon-Like PeptidesGlucagon-Like Peptide-1 Receptor AgonistsCardiovascular DiseasesInjections, SubcutaneousRandomized Controlled Trials as TopicSemaglutide

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsSemaglutide

Autor:innen und Institutionen

  • From the Renal Studies Group, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

ORCID-Profile: William G Herrington

Zitieren

APA

Herrington, W. G., & Haynes, R. (2024). Diabetic Kidney Disease — Semaglutide Flows into the Mainstream. New England Journal of Medicine. https://doi.org/10.1056/nejme2406408

Vancouver

Herrington WG, Haynes R. Diabetic Kidney Disease — Semaglutide Flows into the Mainstream. New England Journal of Medicine. 2024. doi:10.1056/nejme2406408

BibTeX
@article{Herrington2024,
  author = {Herrington, William G and Haynes, Richard},
  title = {Diabetic Kidney Disease — Semaglutide Flows into the Mainstream},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejme2406408}
}
Kostenlos starten →